business
Canaccord raises Waldencast stock price target on Obagi sale
Canaccord raises Waldencast stock price target on Obagi sale
Read full story on Investing.com → More top storiesAlso covered by
Yahoo Finance
BTIG Raises Price Target on Core Scientific (CORZ) Following Power Capacity Expansion
Yahoo Finance
H.C. Wainwright Raises Price Target on Immunovant (IMVT) Following Positive Rheumatoid Arthritis Trial Data
Yahoo Finance
Compass Point Raises Price Target on Nebius Group (NBIS) Following Strong AI Cloud Growth
Yahoo Finance
Compass Point Raises Price Target on Applied Digital (APLD) Following Major AI Data Center Lease Agreement
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop